TenSixty Bio
formerly TenSixty BiosciencesTransforming drug development through AI and cell biology
Cambridge, United States · Founded 2021 · $7.2M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- tensixty.bio
- Total Funding
- $7.2M
- Last Round
- $7.2M Series AAug 2022
- Rounds
- 1
About
TenSixty Bio applies AI, cell models, and high-throughput assays to identify antibody targets and develop oncology therapeutics. The team brings interdisciplinary expertise spanning biology, machine learning, and technology development.
Summary
TenSixty Bio is a Life Sciences company based in Cambridge, United States, founded in 2021. It has raised $7.2M in total across 1 round, most recently a $7.2M Series A round in Aug 2022.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2022
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tensixty-bio"><img src="https://indexed.vc/api/badge/company/tensixty-bio" alt="TenSixty Bio on Indexed.vc" width="260" height="76" /></a>